| Fluidigm Corporation |
| Fluidigm Corporation's mission is to develop, manufacture, and distribute systems composed of integrated fluid circuits (IFCs), instrumentation, and consumables, enabling new efficiencies in science and industry. The Company's product pipeline includes the TOPAZ® system for protein crystallization, introduced in 2002 and tracking toward profitability by 2006; the BioMark™ system for genetic analysis, launched in December 2006; and other projects, co-developed with external partners, to address diverse applications. 1 |
| |
| GenVault Corporation |
| GenVault Corporation provides integrated archiving and retrieval solutions for organizations managing DNA collections. Future systems will also accommodate proteins and RNA to provide a comprehensive solution.
1 |
| |
| Tethys Bioscience |
| Tethys Bioscience is dedicated to the discovery, development and commercialization of novel biomarkers that provide a practical tool to address the growing global challenge of chronic metabolic diseases such as diabetes.1 |
| |
| 1 |
|
Investment made by Cross Creek Capital, L.P. |
|
| 2 |
|
Investment made by one or more members of the Cross Creek Capital team on behalf of Wasatch's clients since January 1, 2004. This investment was made prior to the formation of Cross Creek Capital. |
|